Xeris Pharmaceuticals Inc reported $-21831000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acelrx Pharmaceuticals ACRX:US USD -6750000 77.41M
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
JAZZ PHA JAZZ:US USD -19648000 54.31M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M